Metformin has a long history as a substance with some medical value. It dates back even before its official recognition in 1918 for its ability to reduce blood sugar levels. Before any medical knowledge about diabetes, herbalists utilized a plant called Galega officinalis (also known as goat’s rue or French Lilac) to treat people who […]
There’s been a rapid revolution in how U.S. insurers cover (or don’t cover) the cost of the newer type 2 diabetes medications like Ozempic and Mounjaro. In this short article, we offer a general overview of the highly volatile situation concerning insurance coverage for Ozempic. We aren’t trying to predict what could be happening for […]
In August 2023, we published an in-depth article that focused on a significant improvement in the treatment of both heart and kidney diseases coming from the widespread introduction of new diabetes medications that are based on GLP-1 (glucagon-like peptide-1) receptor agonists (such as Ozempic, Semaglutide, and Mounjaro.) One of our readers posted a question as […]
Often, in the world of medicine, progress is made in unexpected ways. Researchers sometimes find solutions to problems not by carefully planned experiments but by happy accidents. A prime example of this is in recent advancements in treating heart and kidney disease with new families of medications initially intended to treat people with type 2 […]
A natural question has arisen. “If it has such great benefits and is so popular, why do people stop taking Ozempic ?” Ozempic is considered a “wonder drug” out of all the treatments for type 2 diabetes, which has brought significant benefits to millions of people worldwide who develop type 2 diabetes, and caused shortages […]
There is a widely-held public view that drug companies and pharmacies in the US gouge the public relentlessly without care for the public good or ethics. From that perspective, the complaint is that the only thing that matters to the companies is their bank balances. One of the unfortunate targets of this prevailing thinking is […]
What is Diabetes Alert Day? Since 1987, the American Diabetes Association has named the 4th Tuesday in March as Diabetes Alert Day. This year it falls on March 28th. Diabetes Alert Day was created as a public “wake-up call” to the seriousness of diabetes and the importance of understanding the associated risks of living with […]
On January 20th, the FDA announced approval of a new sodium-glucose cotransporter 2 (SGLT2) inhibitor for treatment of type 2 diabetes in adults. The new drug is produced by Theracos, a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The drug will be marketed under the name Brenzavvy (generic name: bexagliflozin). The […]
In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide. Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.